A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas (NCT05934838)

🔬

Loading study...

A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas (NCT05934838) | TrialReferrals